Sort by
Refine Your Search
-
In the compelling and unstoppable research in favor of cellular rejuvenation, Sentcell LTD is looking for PhD or Postdoc Researchers to investigate molecular mechanisms and innovative therapies
-
The Institute of Medical Bioinformatics and Systems Medicine (IBSM) at the Medical Center – University of Freiburg is looking for the next possible date for a PhD / PostDoc Medical bioinformatics (m
-
be in the process of either completing their PhDs and/or have received their PhD after May 1, 2023. Fellows must have completed their doctoral degree prior to starting their Fellowship term. Edwin Land
-
scientist who is excited to develop computational approaches with wide applicability in the life sciences. You should hold a PhD degree in computer science or physics and should have a strong background in
-
useful for biological discovery. You should hold a PhD degree in physics or engineering and should have a strong background in optics and developing complex microscope hardware. Experience building
-
Technology of relevance to the specific PhD position, including laboratory experience Motivation to work at the interface of disciplines (Chemistry, Biology, Engineering and Physics) Good interpersonal
-
Clinician Researcher/Group Leader in Cancer Cell Therapies About QIMR Berghofer: QIMR Berghofer is a world-leading translational medical research institute focused on improving health by developing
-
Postdoc in CRISPR Meta-Analytics and AI for Therapeutic Target Discovery and Priotisation (OT Grant)
presenting advances and results to Open Targets meetings and Integration days. Job requirements Essential requirements Hands-on experience in data science, preferably life sciences or medicine. A PhD degree
-
and science. Qualifications:Minimum Qualifications MD or PhD in basic science, health Science, physics, chemistry, biomedical engineering or related fields. excellent communication in English and
-
that are physiologically important for a healthy immune system. We are interested in the next generation of therapeutics that will be personalized and only target the original disease process. Such treatments can only be